Literature DB >> 12502362

Unique structure-activity relationship for 4-isoxazolyl-1,4-dihydropyridines.

Gerald W Zamponi1, Stephanie C Stotz, Richard J Staples, Tina M Andro, Jared K Nelson, Victoria Hulubei, Alex Blumenfeld, Nicholas R Natale.   

Abstract

A series of 4-isoxazolyl-1,4-dihydropyridines (IDs) were prepared and characterized, and their interaction with the calcium channel was studied by patch clamp analysis. The structure-activity relationship (SAR) that emerges is distinct from the 4-aryldihydropyridines (DHPs), and affinity increases dramatically at higher holding potentials. Thus, among the 3'-arylisoxazolyl analogues p-Br > p-Cl >> p-F, and p-Cl > m-Cl > o-Cl >> o-MeO. Four of the analogues were examined by single-crystal X-ray diffractometry, and all were found to adopt an O-exo conformation in the solid state. The calculated barrier to rotation, however, suggests that rotation about the juncture between the heterocyclic rings is plausible under physiological conditions. A variable-temperature NMR study confirmed the computation. With Striessnig's computational sequence homologation procedure, a working hypothesis was derived from the data that explains the unique SAR for IDs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502362     DOI: 10.1021/jm020354w

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Lanthanide and asymmetric catalyzed syntheses of sterically hindered 4-isoxazolyl-1,4-dihydropyridines and 4-isoxazolyl-quinolones.

Authors:  Scott A Steiger; Chun Li; Charles F Campana; Nicholas R Natale
Journal:  Tetrahedron Lett       Date:  2016-01-20       Impact factor: 2.415

2.  Synthetic Utility of Epoxides for Chiral Functionalization of Isoxazoles.

Authors:  Jared K Nelson; Christopher T Burns; Miles P Smith; Brendan Twamley; N R Natale
Journal:  Tetrahedron Lett       Date:  2008-05-05       Impact factor: 2.415

3.  Dimeric isoxazolyl-1,4-dihydropyridines have enhanced binding at the multi-drug resistance transporter.

Authors:  Scott A Steiger; Chun Li; Donald S Backos; Philip Reigan; N R Natale
Journal:  Bioorg Med Chem       Date:  2017-04-08       Impact factor: 3.641

4.  Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.

Authors:  Vinicius M Gadotti; Chris Bladen; Fang Xiong Zhang; Lina Chen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2015-08-19       Impact factor: 3.657

5.  4-Isoxazolyl-1,4-dihydropyridines exhibit binding at the multidrug-resistance transporter.

Authors:  Victoria Hulubei; Scott B Meikrantz; David A Quincy; Tina Houle; John I McKenna; Mark E Rogers; Scott Steiger; N R Natale
Journal:  Bioorg Med Chem       Date:  2012-09-25       Impact factor: 3.641

6.  Improved synthesis of 3-aryl isoxazoles containing fused aromatic rings.

Authors:  Yousef R Mirzaei; Matthew J Weaver; Scott A Steiger; Alison K Kearns; Mariusz P Gajewski; Kevin C Rider; Howard D Beall; N R Natale
Journal:  Tetrahedron       Date:  2012-09-25       Impact factor: 2.457

7.  1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.

Authors:  Chris Bladen; Vinicius M Gadotti; Miyase G Gündüz; N Daniel Berger; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2014-07-03       Impact factor: 3.657

8.  Fluorescent probes of the isoxazole-dihydropyridine scaffold: MDR-1 binding and homology model.

Authors:  Monika I Szabon-Watola; Sarah V Ulatowski; Kathleen M George; Christina D Hayes; Scott A Steiger; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-12-04       Impact factor: 2.823

9.  Synthesis and evaluation of 1,4-dihydropyridine derivatives with calcium channel blocking activity.

Authors:  Chris Bladen; Miyase Gözde Gündüz; Rahime Şimşek; Cihat Şafak; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2013-10-23       Impact factor: 3.657

Review 10.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases.

Authors:  Gerald W Zamponi
Journal:  Nat Rev Drug Discov       Date:  2015-11-06       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.